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Introduction
Formaldehyde-fixation-paraffin-embedding (FFPE) or ultralow
temperature freezing (at @80 to @190 8C) are the two most
commonly employed strategies in tissue preservation for diag-
nostic and research purposes.[1] Although controlled freezing is
considered the best way to preserve biomolecules and live
cells, it requires specialized and costly facilities for tissue pres-
ervation. In addition, unless freezing is performed under high-
pressure or vacuum conditions, tissue fine structure can be dis-
torted, which hampers histological tissue evaluation.[2] On the
other hand, FFPE tissue can be stored at room temperature,
which reduces storage costs, while maintaining tissue architec-
ture.[2b] For these reasons, formaldehyde fixation followed by
paraffin embedding has become the most common procedure
for the long-term preservation of clinical samples, leading to
the generation of large FFPE tissue repositories worldwide.[2b,3]
Routinely, FFPE tissue from diseased and paired control areas
is collected in hospitals for analysis and stored in sample
archives. Because stored FFPE tissue is linked to pathological,
clinical, and outcome information, it represents a tremendous
potential for biomarker discovery and mechanistic studies.[3b,4]
In this regard, there has been growing interest in developing
strategies for mass spectrometry (MS)–proteomic studies on
FFPE tissue in recent years.[3b,5] This is not only due to the pos-
sibility of linking MS–proteomic results to relevant clinical data,
but also because proteins that might be closely linked to a dis-
ease mechanism are present in higher amounts in the tissue of
interest than in blood, which is the most common sample em-
ployed for diagnostic and prognostic clinical assays.[3b,6] How-
ever, MS–proteomic analyses on FFPE tissue are hampered by
Formaldehyde fixation is widely used for long-term mainte-
nance of tissue. However, due to formaldehyde-induced cross-
links, fixed tissue proteins are difficult to extract, which ham-
pers mass spectrometry (MS) proteomic analyses. Recent years
have seen the use of different combinations of high tempera-
ture and solubilizing agents (usually derived from antigen re-
trieval techniques) to unravel formaldehyde-fixed paraffin-em-
bedded tissue proteomes. However, to achieve protein extrac-
tion yields similar to those of fresh-frozen tissue, high-tempera-
ture heating is necessary. Such harsh extraction conditions can
affect sensitive amino acids and post-translational modifica-
tions, resulting in the loss of important information, while still
not resulting in protein yields comparable to those of fresh-
frozen tissue. Herein, the objective is to evaluate cleavable pro-
tein crosslinkers as fixatives that allow tissue preservation and
efficient protein extraction from fixed tissue for MS proteomics
under mild conditions. With this goal in mind, disuccinimidyl
tartrate (DST) and dithiobis(succinimidylpropionate) (DSP) are
investigated as cleavable fixating reagents. These compounds
crosslink proteins by reacting with amino groups, leading to
amide bond formation, and can be cleaved with sodium meta-
periodate (cis-diols, DST) or reducing agents (disulfide bonds,
DSP), respectively. Results show that cleavable protein cross-
linking with DST and DSP allows tissue fixation with morpholo-
gy preservation comparable to that of formaldehyde. In addi-
tion, cleavage of DSP improves protein recovery from fixed
tissue by a factor of 18 and increases the number of identified
proteins by approximately 20% under mild extraction condi-
tions compared with those of formaldehyde-fixed paraffin-em-
bedded tissue. A major advantage of DSP is the introduction
of well-defined protein modifications that can be taken into
account during database searching. In contrast to DSP fixation,
DST fixation followed by cleavage with sodium metaperiodate,
although effective, results in side reactions that prevent effec-
tive protein extraction and interfere with protein identification.
Protein crosslinkers that can be cleaved under mild conditions
and result in defined modifications, such as DSP, are thus
viable alternatives to formaldehyde as tissue fixatives to facili-
tate protein analysis from paraffin-embedded, fixed tissue.
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difficulties related to protein crosslinks generated after formal-
dehyde fixation. Formaldehyde is a reagent that fixes tissue
mainly through the formation of methylene bridges, preferen-
tially between protein primary amines.[2b, 7] The main problem
derives from the reduced solubility of crosslinked proteins,
which results in limited and biased protein extraction from
FFPE tissue.[3b,4] In recent years, this problem has been ad-
dressed, particularly through adaptation of “antigen retrieval
methods” used in immunohistochemistry to allow MS–proteo-
mic studies on FFPE tissue.[5b,d,8] Heating FFPE tissue to fairly
high temperatures (60–115 8C for 20 min–2 h) greatly improves
protein extraction from fixed tissue and is one of the most im-
portant factors for protein recovery.[3b] However, heating pro-
teins to high temperatures can lead to chemical modifications,
aggregation, and loss of informative post-translational modi-
fications. The extent of modification of proteins in fixed tissue
is currently unclear and it is uncertain if all proteins are solu-
bilized under these conditions. Additional information is also
required on how different fixation times or storage periods
might affect crosslink reversal.[3b,6, 8c,9] Furthermore, it is known
that formaldehyde-derived crosslinks are more heterogeneous
and complex than originally assumed, which leads to un-
defined and unspecified modifications on peptides, resulting in
ambiguous or negative results upon matching experimental
data to in silico databases.[2b,3b] This, together with the fact
that formaldehyde fixation does not prevent nucleic acid deg-
radation completely, has led to the investigation of alternative
fixation strategies,[10] including the use of alcohol-based (i.e. ,
Methacarn, UMFIX, FineFIX), zinc-based (Z7), and commercial
non-crosslinking fixatives (i.e. , RCL2, PAXgene, HOPE). Although
these reagents have shown promising results with respect to
tissue morphology and nucleic acid preservation,[10–11] none of
them have replaced formaldehyde. A few MS–proteomic stud-
ies have been performed with alternative, non-crosslinking fix-
atives to show that protein extraction yields and identification
rates approach those of fresh-frozen tissue,[11b,12] but there is
currently no information on the long-term stability of the mor-
phology of tissue sections fixed in this manner.
Cleavable crosslinkers combine the advantage of creating
covalent bonds between proteins for tissue fixation with the
possibility of retrieving proteins under defined chemical condi-
tions for MS-based proteomics analysis. It is, however, currently
not clear whether they can fix tissue with similar success to
that of formaldehyde and the extent to which they can facili-
tate subsequent proteomics analyses. We therefore evaluated
two cleavable crosslinkers, disuccinimidyl tartrate (DST) and di-
thiobis(succinimidylpropionate) (DSP), as tissue fixatives with
respect to preservation of tissue morphology, protein extrac-
tion yield, and LC-MS/MS-based protein identification rate.
These reagents crosslink proteins through primary amino
groups with two potential advantages over formaldehyde:
1) the crosslinking reaction is more specific, leading to the gen-
eration of fewer side products ; and 2) the protein crosslinks
can be cleaved under mild, chemically defined conditions. Be-
cause protein crosslinks are cleaved prior to protein extraction,
we expect that protein recovery will be higher than that of
FFPE tissue. In addition, the introduction of defined protein
modifications is expected to facilitate peptide identification by
database searching of MS/MS spectra. To assess these charac-
teristics, we evaluated FFPE, DST, and DSP fixation on rat liver
tissue and compared them with fresh-frozen tissue.
Results and Discussion
Peptide modification
A synthetic peptide (N-acetyl-Asn-Leu-Glu-Phe-Lys-NH2-amide),
with a single primary amino group, was used as a model to
identify modifications that might be introduced by DST and
DSP. The peptide was reacted with DSP or DST, followed by re-
action of the resulting products with DTT/iodoacetamide or
sodium metaperiodate, respectively.
In both cases, modification of the primary amino group on
lysine was observed. If DSP is used, the main product corre-
sponds to the addition of hydrolyzed DSP to the peptide
(C5H7O2S2 ; Scheme 1A). Reaction with DTT and iodoacetamide
led to cleavage and alkylation of the thiol, which resulted in
the addition of C5H7N1O2S1 to the peptide, as expected. This
indicates that the main modification after tissue fixation with
DSP and subsequent cleavage/alkylation of the crosslinks with
DTT/iodoacetamide should be a mass increment of 145.120 Da.
Reacting the peptide with DST resulted in the addition of
hydrolyzed DST (C4H4O5, +132.006 Da), which led to the addi-
tion of C2H2O3 and C2O2 (+74.000 and +55.990 Da) after cleav-
Scheme 1. Reaction products after A) DSP or B) DST modification and crosslinker cleavage.
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age with sodium periodate (Scheme 1B). In addition to this
expected peptide modification, another product corresponding
to the addition of 160.000 Da was observed. We were unable
to assign this mass increase to any theoretically expected DST
modification. Treatment with sodium periodate had no effect
on this product.
Tissue surrogate generation and SDS-PAGE analysis
Tissue surrogates (TSs) are formed if proteins are crosslinked.
They are an easy way to evaluate whether a crosslinker can be
employed as a tissue fixative.[13] Figure 1A shows that both
crosslinkers result in lysozyme TSs; this indicates that both re-
agents lead to protein crosslinking under the employed condi-
tions and could serve as fixatives. This was confirmed by non-
reducing SDS-PAGE on TSs formed after 30 min and 24 h. The
addition of extraction buffer (2% SDS, 8m urea in 50 mm Tris
buffer pH 7.6) to the TSs formed after 30 min led to complete
(formaldehyde-TS, form-TS) or partial (DST- and DSP-TSs) solu-
bilization. There was still some monomeric lysozyme in all
cases in the solubilized portion next to dimers and higher
order multimers (Figure 1B, lanes 3–5). On the other hand, the
addition of extraction buffer to 24 h TSs did not allow the solu-
bilization of lysozyme from the formaldehyde TS, whereas
small amounts of solubilized monomer and dimers were ob-
served for the DST- and DSP-TSs (Figure 1B, lanes 6–8). This in-
dicates that the initial kinetics of formaldehyde crosslinking are
slower than those for DST and DSP, due to the higher reactivity
of N-hydroxysuccinimide (NHS) esters, but that crosslinking is
complete with formaldehyde after 24 h, whereas some soluble
protein is left for DST and DSP. This indicates that hydrolysis of
NHS esters in DSP and DST, under aqueous conditions at
pH 7.5, brings the crosslinking reaction to a halt prior to com-
pletion, whereas formaldehyde continues to react. Because
tissue fixation requires 24 h of incubation to allow diffusion of
the crosslinker throughout the tissue, anhydrous conditions
were employed in subsequent experiments to avoid hydrolysis
of the NHS esters before crosslinking was complete.
Incubating the 24 h DSP-TSs with cleavage solution (15 mm
DTT/30 mm iodoacetamide) resulted in solubilization of lyso-
zyme with very little or no dimers and multimers remaining
(Figure 1B, lane 10). Similar results were observed after incuba-
tion of 24 h DST-TSs with 15 mm sodium metaperiodate (Fig-
ure 1B, lane 9). These initial results confirm that DSP and DST
crosslinks can be cleaved and that MS–proteomic analysis after
tissue fixation should be favored for these crosslinkers.
Tissue fixation and protein extraction/identification from
fixed tissue
Rat liver tissue slices were fixed with DST or DSP under anhy-
drous conditions (DMSO) to avoid hydrolysis of the NHS ester
moieties and to maintain the reactivity of the crosslinkers for
24 h. Fixed tissue was embedded in paraffin, hematoxylin and
eosin (H&E) stained, and compared with FFPE tissue. Both DST
and DSP allow preservation of the tissue architecture in a way
that is comparable to that of formaldehyde (Figure 2). The only
difference between formaldehyde and DST/DSP fixation is the
less intense eosin staining in DST/DSP-fixed tissue, which can
be explained by the fact that these reagents convert primary/
secondary amino groups into amides that are no longer pro-
tonated (positively charged), leading to reduced binding of the
anionic dye eosin.[14]
We subsequently investigated the effect of crosslinking and
cleavage on protein extraction and identification for different
fixation strategies under mild extraction conditions. To do so,
we compared the total amount of protein extracted from
fresh-frozen tissue to that of nonfixed paraffin embedded (PE),
FFPE, DST-FPE, and DSP-FPE tissue (three biological replicates
in all cases). After protein extraction, proteins were precipitat-
ed, digested, and the peptides were analyzed by LC-MS/MS.
Table 1 shows that the different steps needed for paraffin re-
moval and tissue rehydration lead to protein loss (ca. 30%) in
comparison with PE and fresh-frozen tissue in the absence of
any fixation. On the other hand, extraction of PE tissue and
DSP-fixed tissue gave similar amounts of extracted protein;
this indicates that DSP fixation followed by cleavage does not
affect protein extraction and that losses relative to fresh-frozen
Figure 1. A) Surrogate tissue formation from lysozyme. Left to right: control
(lysozyme), formaldehyde tissue surrogate (Form-TS), DST tissue surrogate
(DST-TS), DSP tissue surrogate (DSP-TS). B) SDS-PAGE analysis of TS formation
and solubilization due to crosslinker cleavage. Lane 1: marker, lane 2: con-
trol, lane 3: Form-TS after 30 min of reaction, lane 4: DST-TS after 30 min of
reaction, lane 5: DSP-TS after 30 min of reaction, lane 6: Form-TS after 24 h
of reaction, lane 7: DST-TS after 24 h of reaction, lane 8: DSP-TS after 24 h of
reaction, lane 9: DST-TS treated for 24 h with 15 mm sodium metaperiodate,
lane 10: DSP-TS treated for 24 h with 15 mm DTT/30 mm iodoacetamide.
ChemBioChem 2018, 19, 736 – 743 www.chembiochem.org T 2018 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim738
Full Papers
tissue are due to the paraffin removal and tissue rehydration
steps.
DST fixation and sodium metaperiodate cleavage led to sig-
nificantly reduced protein extraction compared with that of
DSP, but was still slightly higher than that for formaldehyde
fixation (3 times more protein extracted).
To investigate whether cis-diol cleavage did occur in DST-
fixed tissue, we performed periodic acid–Schiff (PAS) staining.
During PAS staining, the tissue is incubated with periodic acid
to generate reactive aldehyde groups that further react with
pararosaniline to form a Schiff base; this gives the tissue a
characteristic pink color. In the case of liver tissue, it is necessa-
ry to remove glycogen by pretreatment with a-amylase to
avoid interference.[15] There is strong PAS staining for FFPE and
DST-PE tissue prior to treatment with a-amylase (Figure 3, left),
whereas only DST-PE tissue gave strong PAS staining after gly-
cogen removal (Figure 3, right). This confirmed that metaperio-
date-mediated cleavage of the DST crosslinker was successful,
leading to reactive aldehyde groups.
We hypothesize that low protein extraction after DST fixa-
tion and cleavage may be due to further reaction of the gener-
ated reactive aldehyde groups with amino groups, for exam-
ple, in proteins, possibly leading to renewed crosslinking,
which hampers protein extraction.
To assess the extent to which protein identification rates
could be improved, equal amounts of extracted protein were
digested by trypsin and subjected to LC-MS/MS analysis fol-
lowed by database searching. This resulted in comparable
numbers of identified proteins for fresh-frozen, PE, and DSP-
fixed tissue (Table 2).
FFPE tissue gave a slightly lower number of identified pro-
teins (ca. 85%), whereas DST-fixed tissue led to a clearly re-
duced identification rate (ca. 55% that of fresh-frozen tissue).
Average sequence coverage per protein was low for DST-fixed
tissue (8%) and was clearly higher for DSP-fixed tissue (14%).
Sequence coverage was highest for fresh-frozen and PE tissue
(27–28%) and only slightly lower for FFPE tissue (24%)
(Table 2). The low sequence coverage for DST might be due to
Figure 2. H&E staining of rat liver tissue slices fixed with 4% (w/v) formalde-
hyde (A), 1% (w/v) DST in dry DMSO (B), or 1% (w/v) DSP in dry DMSO (C).
Table 1. Amount of protein extracted from the same amount of fresh-
frozen liver tissue and from PE, DSP-FPE, DST-FPE, and FFPE fixed tissue.
Total protein concentration Relative to Relative to
Mean (n=3, RSD [%] fresh-frozen [%] PE [%]
mg per slice)
fresh-frozen 143 5 100
PE 99 12 69 100
DSP-FPE 91 18 64 93
DST-FPE 15 41 10.5 22
FFPE 5 38 3.5 7
[a] Measurements were performed by Micro BCA assay (see the Experi-
mental Section). Mean and relative standard deviation (RSD) values from
three biological replicates are given.
Figure 3. PAS staining of rat liver tissue slices fixed with 4% (w/v) formalde-
hyde (FFPE) A) prior to and B) after glycogen removal, and fixed with 1% (w/
v) DST in dry DMSO (DST-FPE) C) prior to and D) after glycogen removal.
Table 2. Number of proteins and number of modified proteins identified
by LC-MS/MS from fresh-frozen liver, PE, DSP-FPE, DSP-FPE and FFPE liver
tissue using equal amounts of protein.
No. of proteins identified No. of modified
proteins identified
Mean RSD [%] Av. sequence Mean RSD [%]
coverage [%]
fresh-frozen 623 2 28 – –
PE 597 0.4 27 – –
DSP-FPE 611 1 14 433 3
DST-FPE 337 17 8 4 83
FFPE 511 2 24 – –
Mean and RSD values from three biological replicates are given.
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ill-defined protein modifications, as observed at the peptide
level, and to renewed crosslinks that cannot be taken into ac-
count during database searching. LC-MS/MS analysis and data-
base searching resulted, on average, in only 4 proteins with
the expected DST modifications out of a total of 337 identified
proteins (Table 2), whereas DSP gave 433 modified proteins
out of 611 identified proteins. The reason for the reduced se-
quence coverage for DSP is currently unexplained, but might
also be due to modifications that were not taken into account,
such as oxidation of sulfur or the recently described cross-reac-
tivity of iodoacetamide with methionine.[16]
Conclusion
Cleavable crosslinkers allow reversible tissue fixation with pres-
ervation of microscopic morphology, while, at the same time,
facilitating MS–proteomic analysis. Evaluation of these aspects
was based on 1) a model peptide to identify possible modifica-
tions that might be introduced into fixed proteins, 2) a “surro-
gate tissue” model to investigate DST/DSP crosslinking capabil-
ities and the effect of cleavage on protein solubility, and 3) rat
liver tissue to assess the preservation of tissue morphology
and the effect on protein extraction and LC-MS/MS-based pro-
tein identification.
One of the main challenges in MS–proteomic analysis of
FFPE tissue is defining the exact modifications that affect
proteins during tissue fixation. Formaldehyde fixation leads to
the formation of crosslinked intra- and interprotein networks.
Furthermore, formaldehyde fixation can lead to the formation
of adducts and reaction products different from those of the
expected methylene bridges.[2b,13a] Although some of these re-
actions have been described, the identification of the precise
protein modifications that occur in FFPE tissue requires further
investigation. It is possible that other (not yet identified) pro-
tein modifications are formed during the process, which leads
to negative results upon matching experimental MS/MS spec-
tra to those generated in silico from peptides in a given se-
quence database. Thus, the successful analysis of fixed tissue
relies not only on proper extraction, denaturation, and protein
digestion, but also on the precise knowledge of possible pep-
tide modifications. Taking all of this into consideration, our first
objective was to investigate which modifications DSP and DST
introduced into proteins during tissue fixation. To achieve this
objective, we employed a synthetic peptide (N-acetyl-Asn-Leu-
Glu-Phe-Lys-NH2-amide) as a model because it allowed easy
monitoring of different reactions and interpretation of the re-
sults. Our results show that lysine-containing peptides are
modified by DST or DSP through the addition of C2H2O3 or
C2O2 (+74.000, +55.990 Da) and C5H7N1O2S1 (145.120 Da), re-
spectively. In addition, DST leads to an unspecific modification
of +160.000 Da, which we could not assign to expected DST
modification products. The DSP crosslinking reaction is more
specific, which results in well-defined reaction products. This
indicates that DSP crosslinking is advantageous compared with
DST for tissue fixation in view of MS–proteomics.
To investigate the capability of DST and DSP to crosslink pro-
teins in tissue and the effect of crosslinker cleavage on protein
extraction from fixed tissue, we employed a surrogate tissue
model based on lysozyme. The surrogate tissue model was
introduced by Fowler et al.[13] to study protein recovery from
archival FFPE tissue. In this model, a protein solution is cross-
linked through the addition of formaldehyde to form a gel
plug that can undergo dehydration and paraffin embedding.
This model has been employed to investigate different proto-
cols for protein extraction from FFPE tissue, protein LC-MS/MS
analysis, and protein identification.[13] Our results show that
DSP and DST generate a TS that can be solubilized under the
employed cleavage conditions. These results indicated that the
investigated cleavable crosslinkers were suitable as reversible
fixatives for MS proteomics. However, we also observed that
crosslinking was not complete after 24 h, in comparison to
formaldehyde under aqueous conditions at pH 7.5. This is
likely due to hydrolysis of the NHS ester moieties during cross-
linking. Subsequent crosslinking reactions were thus per-
formed in anhydrous DMSO. Although tissue architecture was
preserved under these conditions, this is a disadvantage of the
cleavable crosslinkers. Future generations of crosslinkers
should thus combine a water-insensitive activated group for
protein crosslinking with a linker that can be cleaved under
defined and mild chemical conditions, resulting in well-defined
chemical modifications.
Finally, we evaluated the capability of DST and DSP to fix
tissue and preserve its morphology. Our results demonstrate
that both DST and DSP allow preservation of the tissue archi-
tecture in a way that is comparable to that of formaldehyde.
However, the selection of adequate protein crosslink reversal
conditions is crucial. Protein crosslinking reversal should result
in protein extraction from fixed tissue that is comparable to
that of nonfixed tissue and, moreover, should allow compre-
hensive MS–proteomics studies. Our results show that protein
extraction is severely hampered if protein crosslinking is not
fully reversible (DST-FPE and FFPE), whereas extraction yields
similar to those of nonfixed tissue (PE) are obtained if protein
crosslinking is fully reversible (DSP-FPE). In addition, if protein
modifications due to crosslinking are not well defined, protein
identification is affected, even if the same amount of extracted
protein is used (337 proteins in DST-FPE vs. 611 proteins in
DSP-FPE tissue from the same initial extracted protein
amount).
In summary, DSP is a suitable, cleavable fixative that allows
preservation of tissue morphology and MS–proteomic analysis
after paraffin embedding with comparable yields to those of
nonfixed tissue. Under mild extraction conditions, DSP-FPE
tissue compares well to fresh-frozen tissue with respect to pro-
tein extraction yield (64%), which is equivalent to nonfixed PE
tissue (69%), whereas protein recovery from FFPE tissue is only
5%. DSP fixation allows tissue preservation and excellent pro-
tein extraction/identification without the need for harsh extrac-
tion conditions, such as elevated temperature, which might
affect post-translational modifications or certain amino acids
and lead to protein aggregation. Another cleavable crosslinker
DST, which we expected to perform equally well, proved disap-
pointing when it came to the final MS–proteomic analysis be-
cause it introduced ill-defined modifications and did not allow
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the extraction of nearly as much protein after sodium metaper-
iodate mediated cleavage.
Experimental Section
Chemicals : DST and DSP were purchased from Pierce Biotech-
nology (Rockford, USA). Formaldehyde (4% solution) was from Kli-
nipath (Duiven, The Netherlands). University of Wisconsin organ
preservation solution was from DuPont Critical Care (Waukegab,
USA). Angiotensin II, ammonium bicarbonate, a-amylase, b-mer-
captoethanol, d,l-dithiothreitol (DTT), bioreagent-grade DMSO,
Dulbecco’s phosphate-buffered saline (PBS), formic acid, hematoxy-
lin, iodoacetamide, lysozyme, myoglobin, periodic acid, 50 mm
phosphate buffer, Schiff reagent, SDS, sodium metaperiodate,
trizma base, trifluoroacetic acid (TFA), and urea were from Sigma–
Aldrich. Precision Plus Protein Dual Color Standard and Coomassie
Brilliant Blue R-250 staining solution were from BioRad (USA).
NuPAGE MES SDS running buffer was from Novex (Carlsbad, USA).
Acetonitrile (HPLC supragradient grade) and xylol (reagent grade)
were from Biosolve (Valkenswaard, The Netherlands). Trypsin was
from Promega (sequencing-grade modified trypsin), eosin was
from Merck, absolute ethanol (AnalR NORMAPUR) was from VWR
International (Fontenay-sous-bois, France), and water was purified
by means of an Arium Ultrapure water system (conductivity
18.2 MWcm; Sartorius Stedim Biotech, Gçttingen, Germany).
Peptide modification : A synthetic peptide (N-acetyl-Asn-Leu-Glu-
Phe-Lys-NH2-amide) was reacted with DST and DSP followed by in-
cubation with cleavage solutions (15 mm sodium metaperiodate or
15 mm DTT/30 mm iodoacetamide, respectively). For DST or DSP
modification, peptide solution (1 mL; 5 mm in 0.1% formic acid)
was added to DST or DSP (50 mL, 0.4 mgmL@1) in DMSO. The mix-
ture was left to react for 30 min (600 rpm in a thermomixer, room
temperature). Afterwards, DST-derivatized peptides were diluted to
0.5 mL with sodium acetate buffer (50 mm ; pH 5). DST crosslinks
were cleaved by the addition of sodium metaperiodate (1 mL,
750 mm) to the DST-derivatized peptide solution (0.1 mL; 1 h,
600 rpm in a thermomixer, room temperature). DSP-derivatized
peptides were diluted with 50 mm ammonium bicarbonate buffer
to 0.5 mL. DSP crosslinks were cleaved by the addition of DTT
(1 mL, 750 mm ; 30 min, 600 rpm, room temperature) to the DSP-
derivatized peptide solution (0.1 mL) followed by the addition of
1.5m iodoacetamide (1 mL; 30 min, 600 rpm in a thermomixer,
room temperature, in the dark). The different reaction steps were
monitored by LC-MS/MS on an Agilent series 1100 capillary LC
system (Waldbronn, Germany) comprised of a degasser, a binary
pump with stream splitter and flow controller, a thermostated au-
tosampler (4 8C), and a thermostated column compartment (40 8C).
The derivatized peptides were analyzed with an Atlantis dC18
column (Waters; Etten-Leur, The Netherlands; 1.0 mmV150 mm,
particle size 3 mm). Mobile phase A consisted of 0.1% (v/v) formic
acid in ultrapure water. Mobile phase B was 0.1% (v/v) formic acid
in acetonitrile (HPLC-S gradient grade; Biosolve; Valkenswaard, The
Netherlands). The injection volume was 1 mL. Separation was per-
formed with an increasing gradient of B (3–90% at 4%min@1) at a
flow rate of 50 mLmin@1. The mass spectrometer was a Bruker HCT
ultra ETD II ion trap (Bruker Daltonics, Bremen, Germany) with an
ESI source operated in positive mode. Data were acquired over a
scan range of m/z 100–2000. The original MS spectra were ana-
lyzed with the Data Analysis software (Bruker Daltonics, v. 3.4).
Surrogate tissue generation and SDS-PAGE analysis : TSs were
generated as described by Fowler et al.[13b] Briefly, a solution of ly-
sozyme (150 mgmL@1) in phosphate buffer (50 mm, pH 7.5) was
mixed (equal volumes) with a solution (10 mgmL@1) of DST or DSP
in dry DMSO, or a 4% (w/v) solution of formaldehyde, and left to
react overnight. As a control, lysozyme (0.1 mL, 150 mgmL@1) in
phosphate buffer (50 mm, pH 7.5) was mixed with DMSO (0.1 mL).
The protein crosslinking and cleavage processes were monitored
by SDS-PAGE. To do so, 2% SDS (92 mL) and urea (8m) in Tris buffer
(50 mm, pH 7.6) were added to the TSs after 30 min or 24 h reac-
tion times. As a control, a solution of protein (2 mL, 150 mgmL@1 ly-
sozyme in 50 mm phosphate buffer) was mixed with DMSO (2 mL)
before 2% SDS (92 mL) and 8m urea in Tris buffer (50 mm, pH 7.6)
were added. To monitor the cleavage of the crosslinkers, cleavage
solution (92 mL) was added to the TSs. DST-TSs were cleaved with
sodium metaperiodate (15 mm in 50 mm acetate buffer pH 5) for
1 h (600 rpm in a thermomixer, room temperature, in the dark).
DSP-TSs were cleaved with DTT (15 mm, 46 mL) for 30 min at 60 8C
followed by the addition of iodoacetamide (30 mm, 46 mL; 30 min,
room temperature, in the dark). After completion of the reaction,
each sample (8 mL) was mixed with PBS (8 mL) and fivefold-concen-
trated loading buffer (4 mL; 10% SDS, 10 mm DTT, 20% glycerol,
0.2m Tris·HCl pH 6.8, 0.05% Bromophenol Blue). SDS-PAGE was
performed in a Mini-Protein III cell (Bio-Rad) with 4–12% Bis·Tris
gels (NuPAGE, Novex) by loading sample (10 mL). Precision Plus Pro-
tein Dual Color Standard was used as a molecular-weight marker
and 20 times diluted NuPAGE MES SDS solution as running buffer.
Proteins were stained with Coomassie Brilliant Blue R-250.
Tissue fixation, dehydration, paraffin embedding, and staining :
All experiments were approved by the committee for care and use
of laboratory animals of the University of Groningen and were per-
formed according to strict governmental and international guide-
lines. Rat liver tissue slices (diameter 5 mm, about 200 mm thick-
ness, and 5 mg wet weight) were obtained as described previous-
ly,[17] and stored in ice-cold University of Wisconsin organ preserva-
tion solution until fixation. Fixation was performed with 1) 4%
(w/v) solution of formaldehyde, 2) 1% (w/v) solution of DST in dry
DMSO, or 3) 1% (w/v) solution of DSP in dry DMSO, for 24 h at
room temperature. As a control, rat liver tissue slices were pre-
served in University of Wisconsin organ preservation solution for
24 h. The fixed tissue was dehydrated (60% ethanol overnight,
80% ethanol 45 min, 96% ethanol 45 min, 100% ethanol 45 min,
100% ethanol 45 min, 100% ethanol 45 min, xylene 45 min, xylene
45 min, xylene 45 min) and embedded in paraffin (24 h). H&E stain-
ing was performed on 4 mm sections, as described previously.[17]
PAS staining was performed by paraffin removal from 4 mm tissue
sections (Ultraclear 15 min, two times), tissue rehydration (100%
ethanol 2 min, 100% ethanol 2 min, 96% ethanol 2 min, 96% etha-
nol 2 min, 70% ethanol 2 min, water 2 min), treatment with 1%
(w/v) periodic acid in water for 20 min followed by reaction with
the Schiff reagent for 20 min. The PAS staining protocol was also
performed after removal of glycogen by incubation at 37 8C for
30 min with 1000 UmL@1 a-amylase.[15]
Protein extraction from fixed tissue, quantification, and diges-
tion : Fixed PE rat liver tissue slices were deparaffinized (paraffin
melting at 60 8C and removal, washing with xylene (1 mL, 4V),
shaking at 300 rpm, 20 min) and rehydrated (100% ethanol 5 min,
100% ethanol 15 min, 80% ethanol 10 min, 60% ethanol 10 min,
60% ethanol 20 min, water 5 min, water 5 min with shaking at
300 rpm). To cleave the crosslinks, DST-fixed tissue was incubated
with 2% periodic acid (3 h, room temperature, in the dark,
300 rpm) and DSP-fixed tissue was incubated with DTT (250 mm ;
2 h, room temperature, 300 rpm) followed by incubation with io-
doacetamide (500 mm ; 1 h, room temperature, in the dark,
300 rpm). After crosslinker cleavage, the tissue was washed with
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water to remove excess cleavage reagents. Subsequently, tissue
slices were snap frozen (liquid nitrogen) and homogenized with a
mortar and pestle. After tissue grinding, lysis buffer (0.2 mL; 2%
SDS, 50 mm Tris buffer pH 7.6, 8m urea, 0.1m b-mercaptoethanol)
was added, the sample was vortexed for 1 min, and sonicated in a
water bath for 2 min. The sample was centrifuged (14000 rpm for
10 min, Eppendorf Centrifuge 5417R) and the supernatant trans-
ferred to a new Eppendorf tube (protein extract). For total protein
analysis, proteins were precipitated (acetone precipitation, see
below for details) from protein extract (10 mL) and redissolved in
SDS (20 mL, 4%, w/v). This solution (10 mL) was diluted to 0.5 mL
with PBS, and the total protein concentration was determined by
means of the Micro BCA assay (Pierce Protein Research Product,
Thermo Scientific) following the manufacturer’s protocol by meas-
uring the absorbance at l=550 nm on a plate reader (Molecular
Devices, THERMOmax). For proteomics analysis, acetone protein
precipitation was performed on a volume of protein extract cor-
responding to 10 mg protein. After precipitation, proteins were
digested with trypsin. Briefly, trypsin (25 mL; 4 mgmL@1 in 50 mm
ammonium bicarbonate buffer) was added to the precipitated pro-
teins and the mixture was shaken at 600 rpm for 4 h. DTT was
added to the sample to a final concentration of 10 mm and the
sample was incubated for 30 min (60 8C, 600 rpm). After cooling of
the sample, iodoacetamide was added to the sample to a final
concentration of 20 mm and left to react for 30 min (room temper-
ature, in the dark, 600 rpm). After completion of the reaction, tryp-
sin was again added at a trypsin/protein ratio of 1:20 (w/w), and
allowed to react for 16 h at 37 8C. To stop trypsin digestion, TFA
was added to a final concentration of 1% (v/v).
LC-MS/MS analysis and protein identification : MS measurements
were performed on an Ultimate 3000 nano LC system (Dionex, Ger-
mering, Germany) online coupled to a hybrid linear ion trap/Orbi-
trap mass spectrometer (LTQ Orbitrap XL; Thermo Fisher Scientific,
Germany). A digest (1 mL) of each sample was loaded on a C18 trap
column (C18 PepMap, 300 mm i.d. V5 mm, 5 mm particle size, 100 a
pore size; Dionex, The Netherlands) and desalted for 10 min at a
flow rate of 20 mLmin@1 with 0.1% TFA in water. Then the trap
column was switched online with the analytical column (PepMap
C18, 75 mm i.d. V150 mm, 3 mm particle and 100 a pore size;
Dionex, The Netherlands) and peptides were eluted with the fol-
lowing binary gradient: 0–25% solvent B in 120 min followed by
25–50% solvent B for 60 min; solvent A consists of 2% acetonitrile
and 0.1% formic acid in water and solvent B consists of 80% ace-
tonitrile and 0.08% formic acid in water. The column flow rate was
set to 300 nLmin@1. For MS detection, a data-dependent acquisi-
tion method was used: a high-resolution survey scan from 400 to
1800 Th was performed in the Orbitrap instrument (target value of
automatic gain control (AGC) 106, resolution 30000 at m/z 400;
lock mass set to 445.120025 Th (protonated (Si(CH3)2O)6)). Based on
this survey scan, the 5 most intense ions were consecutively isolat-
ed (AGC target set to 104 ions) and fragmented by collision-activat-
ed dissociation (CAD) by applying 35% normalized collision energy
in the linear ion trap. After precursors were selected for MS/MS,
they were excluded for further MS/MS analysis for 3 min.
Bioworks (v. 3.3) was used as peak picking software and data files
were submitted to Mascot (v. 2, Matrix Science, London, UK) to in-
terrogate the nonredundant UniProt database (release 2014_03;
taxonomy: Rattus norvegicus, 7914 entries) for protein identifica-
tion. Peptides with a Mascot ion score >25 (i.e. , a peptide proba-
bility cutoff value of 0.01) were accepted as true identifications.
Modifications: carbamidomethylation of cysteine was set as fixed
and oxidation of methionine as variable modification. Additional
variable modifications were set for DSP modification of lysine
(87.998 and 145.120 Da) and DST modification of lysine (55.990
and 74.000 Da). A maximum of two missed cleavages were al-
lowed. Mass tolerance for precursor ions was set to 10 ppm and
for fragment ions to 0.5 Da. The false discovery rate, as determined
by performing a search against a decoy database, was below 1%.
The MS proteomics data have been deposited with the Proteo-
meXchange Consortium[18] through the PRIDE partner repository
with the dataset identifier PXD002169.
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